Cargando…

AFAP1-AS1 induces cisplatin resistance in non-small cell lung cancer through PI3K/AKT pathway

Cisplatin (DDP)-resistance in non-small cell lung carcinoma (NSCLC) severely influences the prognosis of affected patients. This study aims to uncover the potential role of AFAP1-AS1 in DDP-resistant NSCLC and the underlying mechanism. The expression level of AFAP1-AS1 in DDP-resistant NSCLC patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yang, Hu, Qiang, Wang, Xihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924151/ https://www.ncbi.nlm.nih.gov/pubmed/31897216 http://dx.doi.org/10.3892/ol.2019.11175

Ejemplares similares

miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway
por: Liu, Jiangang, et al.
Publicado: (2018)

MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway
por: Qiu, Chensheng, et al.
Publicado: (2020)

Apoptin‐derived peptide reverses cisplatin resistance in gastric cancer through the PI3K–AKT signaling pathway
por: Zhou, Danyang, et al.
Publicado: (2018)

Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
por: Wu, Li-Mei, et al.
Publicado: (2021)

Agmatine Alleviates Cisplatin-Induced Ototoxicity by Activating PI3K/AKT Signaling Pathway
por: Zhang, Ying, et al.
Publicado: (2022)

Orai3-Mediates Cisplatin-Resistance in Non-Small Cell Lung Cancer Cells by Enriching Cancer Stem Cell Population through PI3K/AKT Pathway
por: Daya, Hiba Abou, et al.
Publicado: (2021)

Glutathione Peroxidase 1 Promotes NSCLC Resistance to Cisplatin via ROS-Induced Activation of PI3K/AKT Pathway
por: Chen, Baishen, et al.
Publicado: (2019)

MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma
por: Zhao, Guangyi, et al.
Publicado: (2013)

Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
Publicado: (2021)

MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway
por: Sun, Dian-min, et al.
Publicado: (2018)

MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route
por: Sun, Butong, et al.
Publicado: (2021)

The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
por: Wu, Dong-ming, et al.
Publicado: (2019)

Klotho Sensitizes Human Lung Cancer Cell Line to Cisplatin via PI3k/Akt Pathway
por: Wang, Yan, et al.
Publicado: (2013)

Inhibitor of DNA binding 3 reverses cisplatin resistance in human lung adenocarcinoma cells by regulating the PI3K/Akt pathway
por: Chen, Fang-Fang, et al.
Publicado: (2018)

LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway
por: Dai, Qingqiang, et al.
Publicado: (2020)

DKK1 Promotes Epithelial–Mesenchymal Transition and Cisplatin Resistance in Gastric Cancer via Activation of the PI3K/AKT Pathway
por: Li, Jian, et al.
Publicado: (2023)

Correction: MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma
por: Zhao, Guangyi, et al.
Publicado: (2013)

Activation of PI3K/Akt pathway by G protein‐coupled receptor 37 promotes resistance to cisplatin‐induced apoptosis in non‐small cell lung cancer
por: Liu, Han, et al.
Publicado: (2023)

Lanthanum Chloride Sensitizes Cisplatin Resistance of Ovarian Cancer Cells via PI3K/Akt Pathway
por: Fang, Shanyu, et al.
Publicado: (2021)

Ubiquitin-specific peptidase 17 promotes cisplatin resistance via PI3K/AKT activation in non-small cell lung cancer
por: Zhang, Shengchao, et al.
Publicado: (2020)

Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways
por: Li, Hefei, et al.
Publicado: (2021)

miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway
por: Yang, Wu, et al.
Publicado: (2020)

MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway
por: Huang, Gang, et al.
Publicado: (2019)

Aloperine inhibits the progression of non-small-cell lung cancer through the PI3K/Akt signaling pathway
por: Liu, Fujuan, et al.
Publicado: (2021)

The protective effects of maltol on cisplatin-induced nephrotoxicity through the AMPK-mediated PI3K/Akt and p53 signaling pathways
por: Mi, Xiao-jie, et al.
Publicado: (2018)

Gou Qi Zi inhibits proliferation and induces apoptosis through the PI3K/AKT1 signaling pathway in non-small cell lung cancer
por: Zhang, Lingling, et al.
Publicado: (2022)

IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways
por: Duan, Shiyu, et al.
Publicado: (2018)

LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway
por: Dai, Qingqiang, et al.
Publicado: (2020)

FGFRL1 affects chemoresistance of small‐cell lung cancer by modulating the PI3K/Akt pathway via ENO1
por: Chen, Rui, et al.
Publicado: (2020)

Protein tyrosine phosphatase receptor type Z1 inhibits the cisplatin resistance of ovarian cancer by regulating PI3K/AKT/mTOR signal pathway
por: Wang, Peng, et al.
Publicado: (2022)

LncRNA TBX5-AS1 Regulates the Tumor Progression Through the PI3K/AKT Pathway in Non-Small Cell Lung Cancer
por: Qu, Qing-hai, et al.
Publicado: (2020)

PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells
por: NAVAEI, ZAHRA NASRPOUR, et al.
Publicado: (2022)

Cloning and characterization of the putative AFAP1-AS1 promoter region
por: Wei, Fang, et al.
Publicado: (2019)

A Review on the Role of AFAP1-AS1 in the Pathoetiology of Cancer
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

Preoperative Oral Carbohydrate Improved Postoperative Insulin Resistance in Rats through the PI3K/AKT/mTOR Pathway
por: Wang, Zhiguo, et al.
Publicado: (2015)

miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway
por: HAN, JING, et al.
Publicado: (2016)

FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway
por: Chen, Enni, et al.
Publicado: (2023)

LncRNA AFAP1-AS1 Induces Gefitinib Resistance of Lung Adenocarcinoma Through the miR-653-5p/AGR2 Axis
por: Zuo, Tao, et al.
Publicado: (2023)

Insulin induces drug resistance in melanoma through activation of the PI3K/Akt pathway
por: Chi, Mengna, et al.
Publicado: (2014)

Wogonin Increases Cisplatin Sensitivity in Ovarian Cancer Cells Through Inhibition of the Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway
por: Xing, Feng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o71bm1g8r966811442vt4f0uev